Releaf Blog
Discover helpful insights on health, wellness, and medical cannabis in our blogs. Explore practical articles covering general medical cannabis info, tips for staying well, and how medical cannabis can assist with specific health conditions.
Latest
Can I get a weekend medical cannabis appointment?
Since opening our doors back in February of 2024, we have worked tirelessly to put together a truly world-class clinical team made up of over 25 highly trained doctors, supported by a unit of nurses, prescribing pharmacists, and patient support staff. They’re here to support you every day of the week.
Who you might meet at Releaf
The medicinal potential of humulene in cannabis: A comprehensive guide
In the latest in our educational series looking beyond the aroma to explore the therapeutic potential of terpenes, we examine humulene. As well as being associated with the distinct, hoppy smell of beer, humulene is one of the most abundant terpenes found in cannabis and has some interesting medicinal properties worthy of further exploration.
How the law changed: UK legalisation of medical cannabis
On the 1st of November 2018, legislation was introduced that was celebrated by patients, families, and advocates all over the UK. The rescheduling of cannabis meant that cannabis-based medicines could be legally prescribed for a range of conditions, marking a historic moment. But how did the law change come about? And has it lived up to the expectations of those who continue to fight for fair access to medical cannabis?
Beyond aroma: How does myrcene enhance medical cannabis?
In the latest in our educational series looking beyond the aroma to explore the therapeutic potential of terpenes, we examine Myrcene, and what it brings to medical cannabis patients in the UK.
Can medical cannabis help people with Ehlers-Danlos syndrome?
Yes, cannabis-based therapy options are showing huge promise in helping reduce chronic pain, sleep disturbances, gastrointestinal upset, muscle spasms and stiffness, anxiety, and also the reliance on heavy (and sometimes totally ineffective) pharmaceutical options that come along with the diagnosis of Ehlers-Danlos syndrome (EDS).